BSE filing, NSE: AFIL. Summary written from the filing by ALFA Finder's alert engine.
Akme Fintrade (India) Ltd: key numbers
- Share price
- ₹7.36
- Market cap
- ₹320.1 Cr
- Revenue (annual)
- ₹148.8 Cr
- Net profit (annual)
- ₹42.32 Cr
- P/E (TTM)
- 7.2×Sector 19.7×
- Promoter holding
- 38.94%-0.08% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akme Fintrade (India) Ltd
All →Akme Fintrade (India) Board Meeting Date
Akme Fintrade intimated that its Board will meet on October 30, 2026 to approve unaudited financial results for Q2 H1 FY27. Trading window remains closed until 48 hours post-announcement.
Akme Fintrade (India) Debt & Borrowing: ₹50 Cr
Akme Fintrade's board approved ₹50 Crore secured NCD allotment in two series. Series A1 (24 months, 11.40%) and A2 (30 months, 11.60%) will be listed on NSE.
- Value
- ₹50.00 Cr
Akme Fintrade (India) Debt & Borrowing: ₹25 Cr
Akme Fintrade (India) Limited is raising Rs.25 Crore through the issuance of non-convertible debentures. The debt securities are proposed to be listed on the NSE.
- Value
- ₹25.00 Cr
- Execution
- 24 months
Akme Fintrade (India) Debt & Borrowing: ₹50 Cr
Akme Fintrade (India) Ltd approved the issuance of secured, rated, non-convertible debentures (NCDs) aggregating to ₹50 Crore on a private placement basis.
- Value
- ₹50.00 Cr
Akme Fintrade (India) Capital Structure Change
Akme Fintrade received NSE and BSE trading approval for 1.3 crore preferential allotment shares. The company's listed capital rose to 43,97,49,960 shares post-allotment.
Akme Fintrade (India) Board Meeting Date
Akme Fintrade scheduled its Board of Directors meeting for October 10, 2026. The agenda proposes approval of NCDs up to ₹350 Crore on private placement.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.